We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Mini-Organism-on-a-Chip May Replace Test Animals in Drug Studies

By LabMedica International staff writers
Posted on 16 Feb 2015
Print article
Image: Using the compact multi-organ chip (comparable in size to a one-euro piece), and those of three separate microcircuits, researchers can study the regeneration of certain kidney cells (Photo courtesy of Fraunhofer Institute for Material and Beam Technology IWS).
Image: Using the compact multi-organ chip (comparable in size to a one-euro piece), and those of three separate microcircuits, researchers can study the regeneration of certain kidney cells (Photo courtesy of Fraunhofer Institute for Material and Beam Technology IWS).
A team of German biomedical researchers has developed a highly miniaturized micro-circulatory system for testing the response of various body organs to drugs or other chemicals.

Investigators at the Fraunhofer Institute for Material and Beam Technology IWS (Dresden, Germany) and colleagues at the Institute for Biotechnology at the Technical University of Berlin (Germany) have been working at the cutting edge of research dedicated to replacing test animals with relevant, reproducible alternatives.

To this end they developed a "mini-organism-on-a-chip." This system was designed to mimic the physiology of a human being on a scale of 1:100,000. The chip carries a series of micro-compartments that can be loaded with cells from different organs and are connected by a micro-channel circulatory system. A miniature pump is capable of manipulating flow rates of less than 0.5 microliters per second through the channels. This system ensures there is a constant flow of liquid cell culture medium throughout the mini-organism. The exact configuration of the chip—the number of mini-organs and the connection to the micro-channels—can be changed to accommodate different sets of questions and different applications.

“Most medications work systemically— that is to say, on the organism as a whole. In doing so, toxic substances frequently emerge through metabolic processes, which in turn damage only certain organs,” said Dr. Frank Sonntag, project leader at the Fraunhofer Institute for Material and Beam Technology. “We know today that certain kidney cells, the endothelial cells, play a key role in almost every kidney disease. With the in vitro tests to date, there was always the problem that the endothelial cells worked only under current. Here, our multi-organ chip could offer a test environment that would allow you to observe how cells regenerate following an injury."

Related Links:

Fraunhofer Institute for Material and Beam Technology IWS
Institute for Biotechnology at the Technical University of Berlin


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.